8-A12B 1 d58249d8a12b.htm FORM 8-A12B Form 8-A12B

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

Mesoblast Limited

(Exact name of registrant as specified in its charter)

 

 

 

Australia   Not applicable
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

Level 38

55 Collins Street

Melbourne 3000

Australia

Telephone: +61 (3) 9639-6036

(Address of principal executive offices including zip code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

American Depositary Shares,

each representing 5 Ordinary Shares

Ordinary Shares, no par value

 

NASDAQ Global Select Market

NASDAQ Global Select Market*

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ¨

Securities Act registration statement file number to which this form relates:

333-207719

Securities to be registered pursuant to Section 12(g) of the Act:

None

 

* Application to be made for listing, not for trading, but only in connection with the registration of American Depositary Shares pursuant to requirements of the Securities and Exchange Commission.

 

 

 


Item 1. Description of Registrant’s Securities to be Registered

For a description of the securities of Mesoblast Limited (the “Registrant”) being registered hereunder, reference is made to the information set forth under the heading “Description of American Depositary Shares” and “Description of Share Capital” contained in the Registrant’s registration statement on Form F-1 (File No. 333-207719), as initially filed with the Securities and Exchange Commission (the “Commission”) on November 2, 2015, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on the NASDAQ Global Select Market and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: November 9, 2015     MESOBLAST LIMITED
    By:    /s/ Silviu Itescu
      Silviu Itescu
      Chief Executive Office and Executive Director